(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, c ...
Cancer Oct 17, 2012 | not rated yet | 0
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October ...
Cancer Oct 10, 2012 | not rated yet | 0
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer Oct 08, 2012 | not rated yet | 0 |
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer ...
Cancer Sep 17, 2012 | not rated yet | 0
(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.
Cancer Sep 12, 2012 | not rated yet | 0 |
A new drug treatment could offer hope to patients with advanced colorectal cancer who were intolerant of or did not respond to standard treatments, according to an article published in the Lancet Oncology.
Cancer Aug 27, 2012 | not rated yet | 0
Results of a phase 2 randomised trial for patients with advanced differentiated thyroid cancer (DTC) show that those treated with the oral targeted agent vandetanib survived without the disease getting worse for almost twice ...
Cancer Aug 13, 2012 | not rated yet | 0
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published ...
Cancer Aug 08, 2012 | not rated yet | 0
Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.
Cancer Jun 15, 2012 | 5 / 5 (1) | 0 |
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.
Cancer Jun 05, 2012 | not rated yet | 0
The global cancer burden is set to surge more than 75% by 2030, according to new research published Online First in the Lancet Oncology. The rise is predicted to be even larger in the developing world, with the poorest countr ...
Cancer May 31, 2012 | 5 / 5 (2) | 0 |
Despite more than two-thirds of lung cancer cases being diagnosed in people 65 years or older, there have been few trials of treatments in this age group, and it is not known if the standard treatment for patients with inoperable ...
Cancer May 21, 2012 | not rated yet | 0
- Pages: 1 2